Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)

January 29, 2015 updated by: University Hospital, Angers
The primary objective of AID study is to identify the medico-neuropsychological, socio-economic and environmental baseline characteristics of dyads associated with the institutionalization of AD patients.

Study Overview

Status

Completed

Conditions

Detailed Description

In order to reduce Alzheimer Disease (AD) adverse impacts at individual level as well as in terms of expenditures, the development of efficient strategies based on the identification and the correction of risk factors of institutionalization of AD patients proves necessary.

While it has been identified that institutionalization date depends on patients' health characteristics, the role of social, economic and environmental factors still remains few known.

The investigators hypothesized that institutionalization of AD patients could be related not only to medico-neuropsychological patients' characteristics but also to socio-economic and environmental characteristics of dyad (i.e., AD patient and spouse carer), that could modify the delay of institutionalization.

Study Type

Observational

Enrollment (Actual)

207

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49933
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

AD patients and their spouses were recruited in each memory clinic by a physician during the annual follow-up consultation of AD patient based on eligibility criteria.

Description

Inclusion Criteria:

  • Eligibility criteria for AD patients were:

    • Over age 65,
    • Diagnosis of AD according to the NINCDS-ADRDA ( National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association) criteria,
    • Last memory center consultation between 6 and 12 months before the inclusion,
    • Being affiliated to the French health insurance,
    • Living at home,
    • Having a caregiver with inclusion criteria,
    • Agreement of General Practitioner (GP) of AD patient to participate in the study and affiliation of the GP to the national "Association pour le Développement de l'Information Médicalisée" (ADIM) French network.
  • Eligibility criteria for spouse carers were:

    • Over age 65,
    • Being the spouse and the caregiver of AD patient,
    • Being affiliated to the French health insurance,
    • Living at home with AD patient.

Exclusion Criteria:

  • Non inclusion criteria for AD patients and spouse carers were:

    • An inability to understand and speak French,
    • Acute disease in the past month of baseline assessment,
    • Expected moving outside the recruitment area during the follow-up period
    • Concomitant participation in a clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Date of institutionalization of AD patients (standardized questionnaire)
Time Frame: This outcome is assessed at 12 months.
Date of entrance in institution was collected by a standardized questionnaire.
This outcome is assessed at 12 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The increase formal home help services (measured by a standardized questionnaire and coded as a binary variable)
Time Frame: This outcome is assessed at baseline and 12 months.
The use of formal home help services was measured by a standardized questionnaire and coded as a binary variable.
This outcome is assessed at baseline and 12 months.
The delay of institutionalization of AD patients (assessed by a standardized questionnaire and expressed in number of days)
Time Frame: This outcome is assessed at baseline and 12 months.
The delay of institutionalization was assessed by a standardized questionnaire and expressed in number of days.
This outcome is assessed at baseline and 12 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olivier Beauchet, MD, PhD, University Hospital, Angers

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Actual)

February 1, 2013

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

January 13, 2015

First Submitted That Met QC Criteria

January 29, 2015

First Posted (Estimate)

January 30, 2015

Study Record Updates

Last Update Posted (Estimate)

January 30, 2015

Last Update Submitted That Met QC Criteria

January 29, 2015

Last Verified

November 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer Disease

3
Subscribe